For the quantitative determination of human Haptoglobin concentrations in serum-free cell culture supernates, serum, plasma, saliva, and urine.
Contents of Kit
1. Human Haptoglobin Microplate: 96 well polystyrene microplate (12 strips of 8 wells) 2. Human Haptoglobin Conjugate: 21 mL 3. Human Haptoglobin Standard: 400 ng 4. Assay Diluent CD2-210: 2 vials (11 mL/vial) 5. Calibrator Diluent CD6-78: 21 mL 6. Wash Buffer Concentrate: 21 mL 7. Color Reagent A: 12 mL 8. Color Reagent B: 12 mL 9. Stop Solution: 6 mL 10. Plate Sealers: 4 adhesive strips
Storage
Store the unopened kit at 2-8°C. Do not use past kit expiration date.
Precision
Intra-assay Precision (Precision within an assay) Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-assay Precision (Precision between assays) Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
Sensitivity
Twenty-five assays were evaluated and the minimum detectable dose (MDD) of human Haptoglobin ranged from 0.031-0.529 ng/mL. The mean MDD was 0.192 ng/mL. The MDD was determined by adding two standard deviations to the mean optical density value of twenty zero standard replicates and calculating the corresponding concentration.
Standard Curve
Citations
Publication ()
Have you cited DEIA2225 in a publication? Let us know and earn a reward for your research.
Background
The discovery of Zonulin arose from the study of Vibrio cholerae. During the development of the Vibrio cholerae vaccine, some researchers found that while the virulence of the initial recombinant Vibrio cholerae vaccine strains that removed the ctxA gene was dramatically reduced, these attenuated strains were still capable of inducing severe diarrhea even in the absence of cholera toxin. To explain this phenomenon, the researchers proposed zonula occludins toxin (Zot), a protein that regulates intestinal tight junction (TJ) exogenous toxins depolymerize the tightly junctioned structures of the intestine, which allows for increased intestinal epithelial permeability. After removal of Zot, the tight junction structure is restored. Thus, Zot is thought to regulate tight junctions in a rapidly reversible manner. The researchers then further used an affinity chromatography column with immobilized Zot antibody to isolate and purify adhesion proteins from human small intestinal tissues, and obtained an endogenous protein that functionally resembles Zot to depolymerize tightly-connected complexes, and named it zonulin.
Zonulin is a protein with a molecular mass of 47kDa, with a specific N-terminal receptor-binding domain that determines tissue specificity, and a C-terminal tau-like domain that correlates with cytoskeletal rearrangements in intercellular TJs. Proteomic analysis identified zonulin as a precursor of haptoglobin 2. This is the only human endogenous protein that has been identified that can regulate intestinal permeability by affecting the tight junction structure of the intestinal epithelium. This protein can depolymerize the intestinal epithelial tight junction structural complexes, leading to disruption of the intercellular tight junction structures and increased permeability of the intestinal epithelium, which can lead to inflammation by allowing the entry of macromolecular antigenic substances into the tissues in the intestine.
Figure 1. Mechanisms of intestinal dysbiosis due to unregulated zonulin (Source: Heickman LK, et al. 2020)
On the other hand, studies have confirmed that zonulin is not only found in the intestinal tract, but also in various tissues and organs such as the heart and brain. However, zonulin extracted from different tissues and organs differed in their N-termini, suggesting that connexins can respond specifically to particular stimuli as needed. Therefore, the researchers hypothesized that zonulin is not only able to regulate the tight junctions between intestinal epithelial cells, but is also involved in regulating the tight junctions between extra-intestinal epithelial cells and vascular endothelial cells.
References
1. Veres-Székely A, et al. Zonulin as a Potential Therapeutic Target in Microbiota-Gut-Brain Axis Disorders: Encouraging Results and Emerging Questions. Int J Mol Sci. 2023 Apr Wood
2. Heickman LK, et al. Zonulin as a potential putative biomarker of risk for shared type 1 diabetes and celiac disease autoimmunity. Diabetes Metab Res Rev. 2020 Jul;36(5):e3309.19;24(8):7548.
Q: Concentration of sodium azide or thimerosal and 2-mercaptoethanol(or other toxic substances) if it is contained in the product (we would appreciate it if you would send us the documentation to confirm the product).
A: According to the attached MSDS for this product, none of the reagents contain Sodium Azide.
Q: DEIA2225 Human Zonulin ELISA Kit was produced with Baculovirus to follow Cartagena protocol regulation (or not).
A: The standard and the immunogens for the antibodies provided in the kit were not expressed with baculo virus.
Q: The protein in the Standard of this product is recombinant (or not).
A: The standard is not a recombinant protein, it is human haptoglobin from Human serum.
Customer Reviews
My Review for Human Zonulin ELISA Kit
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.
References
IFN-gamma, IL-17A, or zonulin rapidly increase the permeability of the blood-brain and small intestinal epithelial barriers: Relevance for neuro-inflammatory diseases
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Authors: Rahman, Mohammed T.; Ghosh, Chaitali; Hossain, Mohammed; Linfield, Debra; Rezaee, Fariba; Janigro, Damir; Marchi, Nicola; van Boxel-Dezaire, Anette H. H.
Breakdown of the blood-brain barrier (BBB) precedes lesion formation in the brains of multiple sclerosis (MS) patients. Since recent data implicate disruption of the small intestinal epithelial barrier (IEB) in the pathogenesis of MS, we hypothesized that the increased permeability of the BBB and IEB are mechanistically linked. Zonulin, a protein produced by small intestine epithelium, can rapidly increase small intestinal permeability. Zonulin blood levels are elevated in MS, but it is unknown whether zonulin can also disrupt the BBB. Increased production of IL-17A and IFN-gamma has been implicated in the pathogenesis of MS, epilepsy, and stroke, and these cytokines impact BBB integrity after 24 h. We here report that primary human brain microvascular endothelial cells expressed the EGFR and PAR2 receptors necessary to respond to zonulin, and that zonulin increased BBB permeability to a 40 kDa dextran tracer within 1 h. Moreover, both IL-17A and IFN-gamma also rapidly increased BBB and IEB permeability. By using confocal microscopy, we found that exposure of the IEB to zonulin, IFN-gamma, or IL-17A in vitro rapidly modified the localization of the TJ proteins, ZO-1, claudin-5, and occludin.TJ disassembly was accompanied by marked depolymerization of the penjunctional F-actin cytoskeleton. Our data indicate that IFN-gamma, IL-17A, or zonulin can increase the permeability of the IEB and BBB rapidly in vitro, by modifying TJs and the underlying actin cytoskeleton. These observations may help clarify how the gut-brain axis mediates the pathogenesis of neuro-inflammatory diseases. (C) 2018 Elsevier Inc. All rights reserved.
Effects of PrObiotics on the Symptoms and Surgical ouTComes after Anterior REsection of Colon Cancer (POSTCARE): A Randomized, Double-Blind, Placebo-Controlled Trial
JOURNAL OF CLINICAL MEDICINE
Authors: Park, In Ja; Lee, Ju-Hoon; Kye, Bong-Hyeon; Oh, Heung-Kwon; Cho, Yong Beom; Kim, You-Tae; Kim, Joo Yun; Sung, Na Young; Kang, Sung-Bum; Seo, Jeong-Meen; Sim, Jae-Hun; Lee, Jung-Lyoul; Lee, In Kyu
We investigated microbiota changes following surgical colon cancer resection and evaluate effects of probiotics on microbiota and surgical recovery. This randomized double-blind trial was performed at four medical centers in South Korea. Of 68 patients expected to undergo anterior sigmoid colon cancer resection, 60 were eligible, of whom 29 and 31 received probiotics and placebo, respectively, for four weeks, starting at one week preoperatively. Third- and/or fourth-week information on anterior resection syndrome (ARS), inflammatory markers, and quality of life was obtained. Stool sample analysis was conducted after randomization and bowel preparation and at three and four postoperative weeks. Bacteria were categorized into Set I (with probiotic effects) and II (colon cancer-associated). The probiotic group's ARS score showed an improving trend (p =0.063), particularly for flatus control (p =0.030). Serum zonulin levels significantly decreased with probiotics. Probiotic ingestion resulted in compositional changes in gut microbiota; greater increases and decreases in Set I and II bacteria, respectively, occurred with probiotics. Compositional increase in Set I bacteria was associated with reduced white blood cells, neutrophils, neutrophil-lymphocyte ratio, and zonulin.Bifidobacteriumcomposition was negatively correlated with zonulin levels in the probiotic group. Probiotics improved postoperative flatus control and modified postoperative changes in microbiota and inflammatory markers.